Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Type 1 DiabetesChildren & TeensInfectious DiseaseIssue 701

Type of Enterovirus Linked to Type 1 Diabetes

Researchers have homed in on the group B coxsackie viruses....

Advertisement

Although there has been a considerable amount of research describing the link between type 1 diabetes and enterovirus, which is comprised of more than 100 types including the virus responsible for polio, it was not until recently that researchers from two independent studies determined the specific type of enterovirus that can attack the insulin-producing cells in the pancreas and lead to type 1 diabetes.

Enteroviruses can infect anyone; however, they are more common among infants, children and teenagers because of their lack of immunity. One of the two studies that identified the specific type of enterovirus responsible for causing type 1 diabetes involved children at genetic risk from birth until age 15 or diagnosis of the disease. This study was known as the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) study. The other study, known as the VirDiab study, involved children with newly diagnosed diabetes. Both studies identified that the group B coxsackie viruses were associated with the risk of developing type 1 diabetes; whereas no association with the other 35 types was observed. The group B coxsackie viruses include six enteroviruses.

Researchers said that a vaccine against the virus, similar to a polio vaccine, might be an option eventually in preventing or delaying the onset of type 1 diabetes.

Diabetes, October 2013
 
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 01 November, 2013 and appeared in  Type 1 DiabetesChildren & TeensInfectious DiseaseIssue 701

Past five issues: Diabetes Clinical Mastery Series Issue 208 | Issue 748 | GLP-1 Special Editions September 2014 | Diabetes Clinical Mastery Series Issue 207 | Issue 747 |

2014 Most Popular Articles:

Abbott Announces Approval of Its New Unique Continuous Glucose Monitor
Posted September 05, 2014
Low Carb Beats Low Fat
Posted September 05, 2014
FDA Approves Bupropion/Naltrexone (Contrave) for Obesity by Orexigen Therapeutics
Posted September 12, 2014
Lilly's Basal Insulin Peglispro Demonstrated HbA1c Superiority against Lantus
Posted September 05, 2014
An Exclusive Interview with Al Mann, Founder and CEO, Mannkind Corp.
Posted September 15, 2014
Empagliflozin (Jardiance) SGLT-2 Inhibitor Now Available in Pharmacies
Posted August 29, 2014
Sleeve Gastrectomy Now a Common Choice for Bariatric Surgery
Posted September 12, 2014
Type 2 Diabetes Diagnosis Needs to Be Changed: Prediabetes=Diabetes
Posted September 12, 2014
Predicting Which Diabetics Will Develop Major Complications
Posted September 05, 2014
High-salt Diet and High HBA1c May Increase Cardiovascular Disease
Posted September 19, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Now that once-weekly dulaglutide has been approved, will you be prescribing it?
CME/CE of the Week
Patti Geil, MS, RD, FADA, CDE

Category: Nutrition
Credits: .75



Search Articles On Diabetes In Control